You are here

No easy way out for Abbott as deal target faces bribery probe


ABBOTT Laboratories tried to end its US$5.8 billion agreement to buy Alere Inc after finding out in mid- March that the medical-testing company was swept up in a US probe of bribery overseas. Alere's shares, meanwhile, are trading at levels suggesting that investors have their